Cas:144342-49-4 6,6′-dimethyl-2,2′-bipyridine-4,4′-dicarboxylic acid manufacturer & supplier

Chemical Name:6,6′-dimethyl-2,2′-bipyridine-4,4′-dicarboxylic acid

CAS.NO:144342-49-4

Synonyms:4,4′-dicarboxy-6,6′-dimethyl-2,2′-bipyridine;6,6′-Dimethyl-2,2′-bipyridine-4,4′-dicarboxylic acid;[2,2′-Bipyridine]-4,4′-dicarboxylic acid, 6,6′-dimethyl-

Molecular Formula:C₁₄H₁₂N₂O₄

Molecular Weight:272.25600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:100.38000

Exact Mass:272.08000

LogP:2.15680

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4,4′-dicarboxy-6,6′-dimethyl-2,2′-bipyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[2,2′-Bipyridine]-4,4′-dicarboxylic acid, 6,6′-dimethyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6,6′-Dimethyl-2,2′-bipyridine-4,4′-dicarboxylic acid Use and application,6,6′-Dimethyl-2,2′-bipyridine-4,4′-dicarboxylic acid technical grade,usp/ep/jp grade.

Related News: From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats. 6,6′-dimethyl-2,2′-bipyridine-4,4′-dicarboxylic acid manufacturer Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. 6,6′-dimethyl-2,2′-bipyridine-4,4′-dicarboxylic acid supplier From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats. 6,6′-dimethyl-2,2′-bipyridine-4,4′-dicarboxylic acid vendor From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats. 6,6′-dimethyl-2,2′-bipyridine-4,4′-dicarboxylic acid factory GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.��